We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese Manufacturer Receives Warning Letter for API, GMP Violations
Chinese Manufacturer Receives Warning Letter for API, GMP Violations
The FDA hit the Dongying Tiandong Pharmaceutical Co. with a warning letter for failing to investigate and document out-of-specification results when testing drug batches as well as GMP violations.